Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Acne
ADR ID BADD_A00055
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.02      Skin appendage conditions
23.02.01      Acnes
23.02.01.001      Acne
Description A chronic disorder of the pilosebaceous apparatus associated with an increase in sebum secretion. It is characterized by open comedones (blackheads), closed comedones (whiteheads), and pustular nodules. The cause is unknown, but heredity and age are predisposing factors. [MeSH]
MedDRA Code 10000496
MeSH ID D000152
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Acne | Acne aggravated | Acne comedonal | Acne follicular | Acne follicular papular pustular etc | Acne medicamentosa | Acne NOS | Acne papular | Acne scars | Acne steroid | Acne steroid-induced | Acne vulgaris | Blackheads | Comedo | Comedome | Comedone | Exacerbation of acne | Other acne | Pimple | Pimples | Steroid acne | Whiteheads | Acne follicular papular pustular etc. | Hormonal acne | Clogged pores | Adult acne | Acne tarda | Acne Vulgaris
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02396Zonisamide--
BADD_D02407Upadacitinib0.021797%
BADD_D02412Octreotide0.000186%
BADD_D02440Lisdexamfetamine0.001321%
BADD_D02446Prasterone0.022219%
BADD_D02450Crisaborole0.002802%
BADD_D02456Vilazodone0.001246%
BADD_D02457Dexmethylphenidate0.000375%
BADD_D02464Fingolimod0.011863%
BADD_D02468Cannabidiol0.001270%
BADD_D02470Nintedanib--
BADD_D02489Neratinib0.002183%
BADD_D02492Deflazacort0.001241%
BADD_D02496Elagolix0.000727%
BADD_D02510Rucaparib0.001198%
BADD_D02514Etelcalcetide0.004347%
BADD_D02524Ivosidenib0.000381%
BADD_D02527Abrocitinib0.001596%
BADD_D02543Clascoterone0.001467%
BADD_D02549Deucravacitinib0.014756%
BADD_D02580Ozanimod0.002170%
BADD_D02591Ripretinib0.000683%
BADD_D02594Selumetinib0.001063%
BADD_D02597Tapinarof-
BADD_D02601Trifarotene0.012254%
BADD_D02615Bilastine--
The 11th Page    First    Pre   11    Total 11 Pages